序号 | 产品名称 | 产品数量 |
1 | ELR510444 | 7 |
2 | Maleimidocaproyl-L-valine-L-citrulline-p-aminobenzyl alcohol p-nitrophenyl carbonate | 3 |
3 | AL6221 | 3 |
4 | NS-1619 | 4 |
5 | 98791-67-4 | 9 |
6 | (R)-(+)-Bay K 8644 | 5 |
7 | (R)-(+)-Bay-K-8644 | 4 |
8 | R-4407 | 1 |
9 | NI-105 | 1 |
10 | (+)-BAY-K-8644 | 1 |
11 | 1402821-41-3 | 8 |
12 | GV-58 | 8 |
13 | 158798-83-5 | 1 |
14 | 1255517-78-2 | 6 |
15 | ZK200775 hydrate | 2 |
16 | 2-{4-[6-(6-carboxy-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)-1H-benzimidazol-2-yl]phenyl}-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinoline-6-carboxylic acid(5405872) | 1 |
17 | (S)-(-)-Bay K 8644 | 5 |
18 | (S)-(-)-Bay-K-8644 | 6 |
19 | (-)-BAY-R-5417 | 1 |
20 | (-)-BAY-K-8644 | 1 |
21 | 1-phenyl-3-pyrazolidinone | 2 |
22 | (-)-Willardiine | 2 |
23 | Fluocinolone Acetonide | 8 |
24 | UL-FS-49 | 3 |
25 | 111011-53-1 | 4 |
26 | SB-747651A Dihydrochloride | 2 |
27 | Efonidipine hydrochloride | 2 |
28 | NZ-105 | 3 |
29 | SB-747651A | 2 |
30 | 178616-26-7 | 7 |
31 | ChemBridge-5405872 | 1 |
32 | N-(anilinocarbonothioyl)benzamide(5406085) | 1 |
33 | CFM-2 | 7 |
34 | MK0518 potassium | 1 |
35 | Osimertinib mesylate(AZD-9291 mesylate) | 1 |
36 | ChemBridge-5406085 | 1 |
37 | Mereletinib mesylate | 3 |
38 | 1919853-46-5 | 7 |
39 | PTP1B-IN-2 | 8 |
40 | 2-(4-ethoxyphenyl)benzo-1,4-quinone(5406172) | 1 |
41 | 2249801-12-3 | 7 |
42 | MD2-TLR4-IN-1 | 7 |
43 | PI solution | 1 |
44 | 2-Bromohexadecanoic acid | 3 |
45 | Hoechst 33258 trihydrochloride | 3 |
46 | bisBenzimide H 33258 trihydrochloride | 4 |
47 | H 33258 trihydrochloride | 4 |
48 | Hoechst 33258 solution(1mg/mL) | 1 |
49 | Fluorescein diacetate(FDA) | 1 |
50 | m-Tolylacetic acid | 3 |
51 | 607372-46-3 | 2 |
52 | EO 1428 | 5 |
53 | Formoterol Hemifumarate | 5 |
54 | Eformoterol, CGP 25827A, NSC 299587, YM 08316 | 1 |
55 | ChemBridge-5406172 | 1 |
56 | SB-209670 | 1 |
57 | 157659-79-5 | 1 |
58 | CFSE(CFDA-SE) | 1 |
59 | 5(6)-CFDA N-succinmidyl ester | 3 |
60 | Phenoxazone 9 | 3 |
61 | AZD-2327 | 1 |
62 | DiI碘化物 | 2 |
63 | DiI perchlorate | 1 |
64 | DiIC18(3) | 3 |
65 | Vanillyl butyl ether | 2 |
66 | DiO perchlorate | 1 |
67 | Vanillylacetone | 3 |
68 | DiOC18(3) | 1 |
69 | DiR iodide | 2 |
70 | Y-39983 dihydrochloride | 3 |
71 | BRL-4910A | 2 |
72 | 1633044-56-0 | 8 |
73 | Alda-89 | 2 |
74 | TASIN-1 Hydrochloride | 3 |
75 | FIIN-2 | 9 |
76 | Eplivanserin hemifumarate | 5 |
77 | Ralimetinib dimesylate | 3 |
78 | Salbutamol | 3 |
79 | DFO(1,8-Diazafluoren-9-one) | 1 |
80 | 9H-1,8-Diazafluoren-9-one | 2 |
81 | R 51619 | 3 |
82 | (±)-Cisaprid | 3 |
83 | N-(N-Butyl)thiophosphoric triamide | 1 |
84 | NBPT | 1 |
85 | 554403-49-5 | 4 |
86 | 1,3-diallyl-1,3,5-triazinane-2,4,6-trione(5406754) | 1 |
87 | 94-59-7 | 2 |
88 | WAY-181187 | 4 |
89 | 875647-81-7 | 1 |
90 | Ro-46-2005 | 1 |
91 | 2102933-95-7 | 8 |
92 | GSK-LSD1 Dihydrochloride | 7 |
93 | GSK-LSD1 2HCl | 4 |
94 | Chk2 Inhibitor II | 3 |
95 | ChemBridge-5406754 | 1 |
96 | 1,2,3,4,5,6-Hexabromocyclohexane | 4 |
97 | 1198097-97-0 | 9 |
98 | UK-48340 | 2 |
99 | Stenabolic(SR9009) | 1 |
100 | Stenabolic | 2 |